Extra doses of bleeding drug may boost mobility after joint replacement

NCT ID NCT06208267

Recruiting now Symptom relief Sponsor: St. Mary's Research Center, Canada Source: ClinicalTrials.gov ↗

First seen May 01, 2026 · Last updated May 18, 2026 · Updated 2 times

Summary

This study tests whether giving extra doses of tranexamic acid (TXA) after hip or knee replacement surgery can reduce bleeding, pain, and help people move better. TXA is already used during surgery to prevent blood loss. Researchers will compare the usual single dose to additional oral doses given after surgery. About 210 adults having hip or knee replacement at St. Mary's Hospital in Canada will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE BLEEDING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

St. Mary's Hospital Center
RECRUITING

Montreal, Quebec, H3T 1M5, Canada

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

POSTOPERATIVE BLEEDING